Biogen (BIIB) shares recorded their fifth consecutive day of increases, accumulating a total return of 14% during this span. The company’s market value has increased by approximately $3.3 billion over ...
Stocktwits on MSN
BIIB stock ends 3% higher — why this strategist picks Biogen over other biotech peers
Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer’s, unlike many names in the ...
Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that there are new announcements every hour or so, it’s kind of unclear what the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Biogen (NasdaqGS:BIIB) plans to present new investigational data from its Alzheimer’s portfolio at AAIC 2026. The company ...
Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the May 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...
Looking ahead to 2030, our model projects BIIB could trade at an average price of $386.52, with a potential range between $289.89 and $483.15. This represents a potential 81.8% return from today's ...
Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the March 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results